Ligand Pharmaceuticals - Biopharma's Technology and Capital …
Ligand invests in the clinical development and commercialization of high-value medicines. We manage one of the largest and most diverse portfolios of biopharmaceutical royalties in the …
Ligand Pharmaceuticals Incorporated - Investor Relations
Oct 23, 2025 · Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of …
Ligand Reports First Quarter 2025 Financial Results
May 8, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing …
Royalty Portfolio - Ligand Pharmaceuticals
Today, Ligand manages one of the largest and most diverse portfolios of biopharmaceutical royalties in the industry, with more than 90 partnered commercial and development-stage …
Ligand Pharmaceuticals Incorporated - Stock Info
Nov 14, 2025 · All 3m NASDAQ:LGND News Releases Aug 18 Aug 25 Sep 1 Sep 8 Sep 15 Sep 22 Sep 29 Oct 6 Oct 13 Oct 20 Oct 27 Nov 3 Nov 10 2020 2021 2022 2023 2024 2025 140 …
About Us - Ligand Pharmaceuticals
Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value programs …
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel …
Apr 17, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing …
Ligand Pharmaceuticals Incorporated - Ligand Announces Pricing …
Aug 11, 2025 · Ligand partners with other pharmaceutical companies to attempt to leverage what they do best (late-stage development, regulatory management and commercialization) in order …
Ligand Pharmaceuticals Incorporated - Ligand Reports Second …
Aug 7, 2025 · About Ligand Pharmaceuticals Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines.
News & Events - Press Releases - Ligand Pharmaceuticals
Oct 9, 2025 · Download , Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients, October 9, 2025, (opens …